Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids

Human Reproduction

Volumn 17, Issue 10, 2002, Pages 2737-2741

  Hindley, J T ^a   Law, P A ^a   Hickey, M ^b   Smith, S C ^c   Lamping, D L ^c   Gedroyc, W M W ^a   Regan, L ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Fibroid; Laser; MRI; Outcomes; Treatments

Indexed keywords

ARTICLE; BENIGN TUMOR; BLEEDING; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LASER SURGERY; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUATION DISORDER; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SAFETY; SYMPTOM; TREATMENT OUTCOME; TUMOR VOLUME; UTERUS MYOMA;

EID: 0036799684     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.10.2737     Document Type: Article

References (17)

1. Agency for Healthcare Research and Quality, Rockville, MD (2001) Management of Uterine Fibroids. Summary, Evidence Report/Technology Assessment: Number 34. AHRQ Publication NO. 01.E051.
2. Carlson, K.J., Miller, B.A. and Fowler, F.J. (1994a) The Maine Women's Health Study: I. Outcomes of hysterectomy. Obstet. Gynecol., 83, 556-565.
3. Carlson, K.J., Miller, B.A. and Fowler, F.J. Jr. (1994b) The Maine Woman's Health Study II: Outcomes of the non-surgical management of leiomyomas, abnormal bleeding and chronic pelvic pain. Obstet. Gynecol., 83, 556-572
4. Crosignani, P.G., Vercellini, P., Meschia, M., Oldani, S. and Bramante, T. (1996) GnRH analogues before surgery for uterine leiomyomas. A review. J. Reprod. Med., 41, 415-421.
5. Goldfarb, H.A. (1992) Neodymium-Yttrium Aluminum Garnet (YAG) laser laparoscopic coagulation of symptomatic myomas. J. Reprod. Med., 37, 636-638
6. Gunderson, H.J.a nd Jenson, E.B. (1987) The efficiency of systematic sampling in stereology and its prediction. J. Microsc., 3, 229-263.
7. Hallberg, L. (1964) Determination of menstrual blood loss. Scan. J. Clin. Lab. Invest., 16, 244.
8. Iverson, R.E.J., Chelmon, D., Strohbehn, K., Waldman, L. and Evantash, E.G. (1996) Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet. Gynecol., 88, 415-419.
9. Jolesz, F. and Silverman, S.G. (1995) Interventional Magnetic Resonance Therapy. Seminars in Interventional Radiology, 12, 20-27.
10. Kjerulff, K.H., Rhodes, J.C., Langenberg, P.W. and Harvey, L.A. (2000) Patient satisfaction with the results of hysterectomy. Am. J. Obs. Gynaecol., 183, 1440-1447.
11. Lamping, D.L., Rowe, P., Clarke, A., Black, N. and Lessof, L. (1998) Development and validation of the Menorrhagia Outcomes Questionnaire (MOQ). Br. J. Obstet. Gynae., 105, 766-779.
12. Law, P.A., Gedroyx, W.M. and Regan, L. (1999) Magnetic resonance guided percutaneous laser ablation of uterine fibroids. Lancet, 354, 2049-2050.
13. Law, P.A., Gedroyc, W.M.W. and Regan, L. (2000) Magnetic Resonance-Guided Percutaneous Laser Ablation of Uterine Fibroids. J. Mag. Reson. Imaging, 12, 565-570.
14. Lumsden, M., West, C., Thomas, E., Coutts, J., Hillier, H., Thomas, N. and Baird, D.T. (1994) Treatment with the gonadotrophin releasing hormone agonist Goserelin before hysterectomy for uterine fibroids. Br. J. Obstet. Gynaecol., 101, 438-442.
15. Nisolle, M., Smets, M., Malvaux, V., Anaf, V. and Donnez, J. (1993) Laparoscopic myolysis with the Neodymium-Yttrium Aluminium Garnet: YAG laser; J. Gynaec. Surg., 9, 95-99.
16. Stewart, E.A. (2001) Uterine Fibroids, Seminar. Lancet, 357, 293-298.
17. Veasy, B. and Reiter, R.C. (1981) Uterine leiomyomata: Etiology, symptomatology and management. Fertil. Steril., 36, 433-445.